Nomura Holdings
MRNA icon

Nomura Holdings’s Moderna MRNA Stock Holding History

Nomura Holdings’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-349,800
Closed -$10.3M – 1974
2025
Q4 		$10.3M Sell
349,800
-207,800
-37% -$5.65M 0.01% 506
2025
Q3 		$14.4M Sell
557,600
-242,400
-30% -$6.76M 0.02% 399
2025
Q2 		$22.1M Buy
+800,000
New +$21.1M 0.05% 235
2024
Q3 		– Sell
-60,000
Closed -$7.13M – 1817
2024
Q2 		$7.13M Buy
+60,000
New +$7.59M 0.01% 568
2022
Q3 		– Sell
-1,400
Closed -$209K – 1866
2022
Q2 		$209K Sell
1,400
-5,200
-79% -$743K ﹤0.01% 1275
2022
Q1 		$1.17M Buy
6,600
+3,200
+94% +$539K ﹤0.01% 1056
2021
Q4 		$858K Buy
+3,400
New +$994K ﹤0.01% 1258

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nomura Holdings's MRNA Position: Q1 2026 in Review

Nomura Holdings increased its Moderna (MRNA) stake by 18% in Q1 2026, buying an estimated $283K and bringing the position to 40,543 shares worth $2.06M. The position accounts for 0.01% of the portfolio, ranked #918.

Nomura Holdings first reported a position in MRNA in Q3 2019 and has held it in 22 quarters since. The position peaked at $16M in Q2 2024. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Nomura Holdings held 40,543 shares of Moderna worth $2.06M as of Q1 2026.
  • Nomura Holdings bought 6,074 Moderna shares in Q1 2026, an estimated $283K.
  • Moderna made up 0.01% of Nomura Holdings's portfolio in Q1 2026, its #918 holding.
  • Nomura Holdings first reported a position in Moderna in Q3 2019 and has held it in 22 quarters since.
  • Nomura Holdings's Moderna position peaked at $16M in Q2 2024.
  • 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.